| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 75 | 2023 | 1698 | 10.900 |
Why?
|
| Placenta Diseases | 21 | 2023 | 199 | 8.500 |
Why?
|
| Pregnancy Complications, Infectious | 24 | 2022 | 2026 | 4.630 |
Why?
|
| Chorioamnionitis | 9 | 2022 | 155 | 2.620 |
Why?
|
| Pregnancy | 104 | 2023 | 29144 | 2.030 |
Why?
|
| Stillbirth | 15 | 2023 | 346 | 1.970 |
Why?
|
| Premature Birth | 8 | 2023 | 1721 | 1.000 |
Why?
|
| Chorionic Villi | 3 | 2020 | 51 | 0.990 |
Why?
|
| Pathology | 3 | 2013 | 272 | 0.970 |
Why?
|
| Fertilization in Vitro | 7 | 2022 | 1284 | 0.930 |
Why?
|
| Abruptio Placentae | 3 | 2020 | 118 | 0.890 |
Why?
|
| Pregnancy Complications | 6 | 2022 | 2861 | 0.880 |
Why?
|
| Serine Endopeptidases | 4 | 2021 | 1072 | 0.850 |
Why?
|
| Thrombosis | 6 | 2022 | 2968 | 0.840 |
Why?
|
| Live Birth | 4 | 2022 | 512 | 0.830 |
Why?
|
| Embryo Transfer | 3 | 2022 | 510 | 0.830 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2020 | 50 | 0.780 |
Why?
|
| Fetal Death | 7 | 2022 | 448 | 0.750 |
Why?
|
| Uterine Neoplasms | 4 | 2020 | 1513 | 0.750 |
Why?
|
| Pregnancy, High-Risk | 1 | 2020 | 120 | 0.730 |
Why?
|
| Infectious Disease Transmission, Vertical | 11 | 2022 | 1320 | 0.730 |
Why?
|
| Health Care Rationing | 2 | 2014 | 437 | 0.720 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2023 | 333 | 0.710 |
Why?
|
| Streptococcal Infections | 2 | 2018 | 638 | 0.700 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2020 | 255 | 0.700 |
Why?
|
| Hematoma | 2 | 2022 | 758 | 0.680 |
Why?
|
| Female | 116 | 2023 | 380194 | 0.680 |
Why?
|
| Fetal Diseases | 5 | 2020 | 903 | 0.660 |
Why?
|
| Myofibroblasts | 1 | 2020 | 222 | 0.660 |
Why?
|
| Infant, Newborn | 33 | 2023 | 25625 | 0.650 |
Why?
|
| Perinatal Care | 2 | 2013 | 227 | 0.620 |
Why?
|
| Rhabdoid Tumor | 1 | 2019 | 212 | 0.610 |
Why?
|
| Fetal Growth Retardation | 5 | 2022 | 570 | 0.610 |
Why?
|
| Maternal Age | 1 | 2020 | 802 | 0.600 |
Why?
|
| Trophoblasts | 4 | 2021 | 215 | 0.600 |
Why?
|
| Pregnancy Complications, Hematologic | 3 | 2020 | 183 | 0.600 |
Why?
|
| Tuberculosis, Urogenital | 1 | 2016 | 9 | 0.590 |
Why?
|
| Autopsy | 7 | 2022 | 1020 | 0.580 |
Why?
|
| Placenta Accreta | 3 | 2020 | 225 | 0.560 |
Why?
|
| Placental Insufficiency | 2 | 2017 | 51 | 0.560 |
Why?
|
| HIV Infections | 7 | 2023 | 16718 | 0.550 |
Why?
|
| Perfusion | 1 | 2020 | 1360 | 0.540 |
Why?
|
| Body Patterning | 6 | 2005 | 626 | 0.530 |
Why?
|
| Vascular Diseases | 3 | 2021 | 1161 | 0.530 |
Why?
|
| Obstetrics | 1 | 2022 | 658 | 0.530 |
Why?
|
| Digestive System | 3 | 2002 | 253 | 0.530 |
Why?
|
| Pregnancy Trimester, First | 2 | 2016 | 853 | 0.520 |
Why?
|
| Pregnancy, Ectopic | 1 | 2016 | 141 | 0.500 |
Why?
|
| Hydrops Fetalis | 2 | 2019 | 107 | 0.500 |
Why?
|
| Cryopreservation | 1 | 2019 | 670 | 0.500 |
Why?
|
| Lung Diseases | 2 | 2019 | 1886 | 0.500 |
Why?
|
| Escherichia coli Infections | 1 | 2018 | 532 | 0.490 |
Why?
|
| Uterus | 4 | 2022 | 711 | 0.490 |
Why?
|
| Humans | 128 | 2023 | 744343 | 0.480 |
Why?
|
| Endometrium | 2 | 2016 | 424 | 0.480 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 1442 | 0.460 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 1701 | 0.450 |
Why?
|
| Diabetes, Gestational | 5 | 2016 | 1184 | 0.450 |
Why?
|
| Fetus | 11 | 2022 | 1880 | 0.450 |
Why?
|
| Perinatology | 1 | 2013 | 57 | 0.450 |
Why?
|
| Cephalopelvic Disproportion | 1 | 2012 | 3 | 0.450 |
Why?
|
| Gestational Age | 9 | 2021 | 3493 | 0.440 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2005 | 838 | 0.430 |
Why?
|
| Birth Weight | 7 | 2023 | 2069 | 0.420 |
Why?
|
| Uterine Rupture | 1 | 2012 | 72 | 0.420 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 435 | 0.420 |
Why?
|
| Thrombophilia | 2 | 2007 | 305 | 0.410 |
Why?
|
| Streptococcus agalactiae | 2 | 2018 | 375 | 0.410 |
Why?
|
| Acetamides | 1 | 2013 | 249 | 0.400 |
Why?
|
| In Situ Hybridization | 7 | 2021 | 1950 | 0.400 |
Why?
|
| Lung | 5 | 2022 | 9856 | 0.380 |
Why?
|
| Adult | 50 | 2022 | 214055 | 0.380 |
Why?
|
| Uterine Artery | 1 | 2010 | 36 | 0.380 |
Why?
|
| Uterine Contraction | 2 | 2022 | 93 | 0.380 |
Why?
|
| Endotoxins | 1 | 2013 | 527 | 0.380 |
Why?
|
| Obstetric Labor Complications | 1 | 2012 | 238 | 0.370 |
Why?
|
| Infertility, Female | 1 | 2016 | 787 | 0.360 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2021 | 571 | 0.360 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2017 | 322 | 0.360 |
Why?
|
| Placenta Previa | 1 | 2011 | 117 | 0.350 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2013 | 582 | 0.350 |
Why?
|
| Lymphangiectasis | 1 | 2009 | 17 | 0.350 |
Why?
|
| Maternal Exposure | 1 | 2016 | 961 | 0.340 |
Why?
|
| Air Pollution, Indoor | 1 | 2016 | 857 | 0.340 |
Why?
|
| Wnt Proteins | 4 | 2011 | 721 | 0.330 |
Why?
|
| Chick Embryo | 8 | 2008 | 982 | 0.330 |
Why?
|
| Abdominal Pain | 2 | 2012 | 1063 | 0.330 |
Why?
|
| Trans-Activators | 7 | 2006 | 2924 | 0.330 |
Why?
|
| Phlebitis | 1 | 2008 | 31 | 0.320 |
Why?
|
| Diabetes Complications | 1 | 2015 | 1359 | 0.320 |
Why?
|
| Sepsis | 2 | 2022 | 2593 | 0.320 |
Why?
|
| Uganda | 6 | 2023 | 1243 | 0.320 |
Why?
|
| Leiomyoma | 1 | 2014 | 730 | 0.320 |
Why?
|
| Sarcoma | 1 | 2019 | 1897 | 0.310 |
Why?
|
| Treatment Refusal | 1 | 2011 | 421 | 0.310 |
Why?
|
| Endoderm | 4 | 2005 | 154 | 0.310 |
Why?
|
| Labor, Obstetric | 2 | 2021 | 333 | 0.310 |
Why?
|
| Enteric Nervous System | 3 | 2005 | 189 | 0.300 |
Why?
|
| Umbilical Veins | 1 | 2008 | 433 | 0.300 |
Why?
|
| Women's Health | 2 | 2014 | 2034 | 0.300 |
Why?
|
| Postpartum Hemorrhage | 1 | 2010 | 258 | 0.290 |
Why?
|
| Immunohistochemistry | 9 | 2021 | 11366 | 0.290 |
Why?
|
| Fetal Blood | 3 | 2023 | 1318 | 0.280 |
Why?
|
| Placental Circulation | 3 | 2020 | 40 | 0.270 |
Why?
|
| Recurrence | 1 | 2017 | 8340 | 0.270 |
Why?
|
| Mesoderm | 4 | 2005 | 686 | 0.270 |
Why?
|
| Patient Positioning | 2 | 2020 | 324 | 0.270 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 1832 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
| Ganglia | 1 | 2005 | 89 | 0.260 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2022 | 365 | 0.260 |
Why?
|
| Pathology, Clinical | 2 | 2020 | 368 | 0.260 |
Why?
|
| Gastrointestinal Tract | 3 | 2005 | 814 | 0.250 |
Why?
|
| Blood Transfusion | 1 | 2011 | 1301 | 0.250 |
Why?
|
| Organ Size | 6 | 2019 | 2252 | 0.250 |
Why?
|
| Blood Vessels | 2 | 2008 | 1125 | 0.250 |
Why?
|
| Respiratory System | 1 | 2008 | 557 | 0.250 |
Why?
|
| Cesarean Section | 2 | 2020 | 1365 | 0.240 |
Why?
|
| Vasculitis | 1 | 2008 | 519 | 0.240 |
Why?
|
| Retrospective Studies | 14 | 2023 | 77449 | 0.230 |
Why?
|
| Anemia | 2 | 2023 | 1506 | 0.230 |
Why?
|
| Fetal Distress | 2 | 2022 | 40 | 0.230 |
Why?
|
| Uterine Hemorrhage | 2 | 2017 | 255 | 0.230 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1790 | 0.230 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2012 | 1873 | 0.220 |
Why?
|
| Fibrin | 2 | 2022 | 506 | 0.220 |
Why?
|
| Serotonin | 3 | 2017 | 1017 | 0.220 |
Why?
|
| Diagnosis, Differential | 9 | 2016 | 12959 | 0.220 |
Why?
|
| Neural Crest | 1 | 2005 | 275 | 0.220 |
Why?
|
| HIV-1 | 1 | 2020 | 6939 | 0.220 |
Why?
|
| Hysterectomy | 3 | 2020 | 927 | 0.220 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 1695 | 0.210 |
Why?
|
| Air Pollution | 1 | 2016 | 2286 | 0.210 |
Why?
|
| Pregnancy in Diabetics | 2 | 2015 | 179 | 0.210 |
Why?
|
| Pregnancy Outcome | 7 | 2022 | 2795 | 0.210 |
Why?
|
| Abnormalities, Multiple | 2 | 2018 | 1416 | 0.210 |
Why?
|
| Infarction | 3 | 2012 | 244 | 0.210 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 26 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 2020 | 0.200 |
Why?
|
| Acute Disease | 3 | 2018 | 7149 | 0.200 |
Why?
|
| Amniotic Fluid | 1 | 2023 | 370 | 0.200 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 3176 | 0.200 |
Why?
|
| Hydatidiform Mole | 2 | 2016 | 279 | 0.190 |
Why?
|
| Tanzania | 4 | 2022 | 1346 | 0.190 |
Why?
|
| Fetal Resorption | 1 | 2020 | 17 | 0.190 |
Why?
|
| Intestines | 3 | 2004 | 1924 | 0.190 |
Why?
|
| Kenya | 2 | 2021 | 685 | 0.180 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2020 | 118 | 0.180 |
Why?
|
| Hyperoxia | 2 | 2019 | 262 | 0.180 |
Why?
|
| Chorion | 2 | 2012 | 117 | 0.180 |
Why?
|
| Placentation | 1 | 2020 | 82 | 0.180 |
Why?
|
| Pregnant Women | 2 | 2022 | 568 | 0.180 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 174 | 0.180 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2021 | 134 | 0.170 |
Why?
|
| Young Adult | 10 | 2021 | 56430 | 0.170 |
Why?
|
| Homeodomain Proteins | 3 | 2009 | 2421 | 0.170 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 440 | 0.170 |
Why?
|
| Cytokines | 2 | 2013 | 7322 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2005 | 162 | 0.170 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 131 | 0.170 |
Why?
|
| Oxygen | 3 | 2022 | 4189 | 0.170 |
Why?
|
| Decidua | 2 | 2016 | 86 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 4 | 2016 | 2007 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 820 | 0.170 |
Why?
|
| Chromosome Aberrations | 3 | 2018 | 1813 | 0.160 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2018 | 30 | 0.160 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.160 |
Why?
|
| Embryonic Induction | 1 | 1998 | 149 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4386 | 0.160 |
Why?
|
| Tissue Fixation | 1 | 2019 | 241 | 0.160 |
Why?
|
| Mass Screening | 1 | 2014 | 5255 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2019 | 12208 | 0.160 |
Why?
|
| Spinal Dysraphism | 1 | 2020 | 161 | 0.160 |
Why?
|
| RNA, Viral | 3 | 2022 | 2902 | 0.160 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 2645 | 0.150 |
Why?
|
| Signal Transduction | 13 | 2017 | 23403 | 0.150 |
Why?
|
| HIV | 2 | 2022 | 1604 | 0.150 |
Why?
|
| Gene Fusion | 1 | 2020 | 371 | 0.150 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2022 | 482 | 0.150 |
Why?
|
| Cause of Death | 4 | 2021 | 3584 | 0.150 |
Why?
|
| Hysterosalpingography | 1 | 2016 | 30 | 0.150 |
Why?
|
| Biopsy | 3 | 2020 | 6756 | 0.150 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2017 | 54 | 0.140 |
Why?
|
| Hedgehog Proteins | 6 | 2006 | 783 | 0.140 |
Why?
|
| Hypospadias | 1 | 2017 | 92 | 0.140 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 211 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5137 | 0.140 |
Why?
|
| Triploidy | 1 | 2016 | 3 | 0.140 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2022 | 570 | 0.140 |
Why?
|
| Infant | 7 | 2023 | 35136 | 0.140 |
Why?
|
| Tumor Burden | 2 | 2020 | 1915 | 0.140 |
Why?
|
| Vagina | 1 | 2021 | 825 | 0.140 |
Why?
|
| Umbilical Cord | 3 | 2007 | 180 | 0.140 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 182 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2016 | 155 | 0.130 |
Why?
|
| Nepal | 1 | 2016 | 295 | 0.130 |
Why?
|
| Incidental Findings | 1 | 2020 | 689 | 0.130 |
Why?
|
| Hydrocephalus | 1 | 2022 | 748 | 0.130 |
Why?
|
| Risk Factors | 12 | 2022 | 72290 | 0.130 |
Why?
|
| Morphogenesis | 4 | 2004 | 752 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2020 | 1355 | 0.130 |
Why?
|
| Urethra | 1 | 2017 | 408 | 0.130 |
Why?
|
| Immunization | 1 | 2019 | 1256 | 0.130 |
Why?
|
| Consensus | 2 | 2021 | 2959 | 0.130 |
Why?
|
| Antigens, CD | 4 | 2012 | 4026 | 0.130 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 544 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 4560 | 0.130 |
Why?
|
| Azacitidine | 1 | 2016 | 347 | 0.120 |
Why?
|
| Caspase 3 | 1 | 2017 | 758 | 0.120 |
Why?
|
| Smoke | 1 | 2016 | 227 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1405 | 0.120 |
Why?
|
| Medical Records | 1 | 2020 | 1413 | 0.120 |
Why?
|
| Developing Countries | 4 | 2018 | 2815 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2019 | 694 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 736 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 1170 | 0.120 |
Why?
|
| Granuloma | 1 | 2016 | 319 | 0.120 |
Why?
|
| Adolescent | 8 | 2021 | 85781 | 0.120 |
Why?
|
| Trace Elements | 1 | 2015 | 198 | 0.120 |
Why?
|
| Cooking | 1 | 2016 | 313 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 961 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2015 | 11725 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2020 | 35421 | 0.120 |
Why?
|
| Vitamin A | 1 | 2017 | 615 | 0.110 |
Why?
|
| Foot | 1 | 2017 | 527 | 0.110 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 12072 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2018 | 1094 | 0.110 |
Why?
|
| Hypertension | 2 | 2018 | 8480 | 0.110 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 531 | 0.110 |
Why?
|
| Reference Values | 2 | 2019 | 4982 | 0.110 |
Why?
|
| Uterine Inertia | 1 | 2012 | 29 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15076 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1547 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2023 | 21746 | 0.110 |
Why?
|
| HLA-C Antigens | 2 | 2012 | 147 | 0.110 |
Why?
|
| Zinc | 1 | 2017 | 684 | 0.110 |
Why?
|
| Insulin | 3 | 2017 | 6580 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 840 | 0.110 |
Why?
|
| Oocyte Donation | 1 | 2012 | 49 | 0.100 |
Why?
|
| Receptor, Insulin | 1 | 2016 | 846 | 0.100 |
Why?
|
| Mothers | 1 | 2022 | 2165 | 0.100 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 3966 | 0.100 |
Why?
|
| Puerperal Infection | 1 | 2011 | 46 | 0.100 |
Why?
|
| Family Characteristics | 1 | 2016 | 1000 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1401 | 0.100 |
Why?
|
| Africa | 1 | 2013 | 673 | 0.100 |
Why?
|
| Macrophages | 3 | 2023 | 5655 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2021 | 40561 | 0.100 |
Why?
|
| Prevalence | 4 | 2021 | 15226 | 0.100 |
Why?
|
| Resource Allocation | 1 | 2013 | 341 | 0.100 |
Why?
|
| Africa South of the Sahara | 3 | 2021 | 724 | 0.100 |
Why?
|
| Ethiopia | 1 | 2012 | 495 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3508 | 0.090 |
Why?
|
| Bacteria | 1 | 2021 | 2114 | 0.090 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 116 | 0.090 |
Why?
|
| Genes, APC | 1 | 2011 | 159 | 0.090 |
Why?
|
| Maternal Mortality | 1 | 2013 | 310 | 0.090 |
Why?
|
| Ascitic Fluid | 1 | 2010 | 192 | 0.090 |
Why?
|
| Dietary Supplements | 3 | 2022 | 3297 | 0.090 |
Why?
|
| Data Collection | 1 | 2019 | 3341 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2021 | 2408 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 742 | 0.090 |
Why?
|
| Rupture, Spontaneous | 1 | 2010 | 354 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2004 | 2425 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2009 | 34 | 0.090 |
Why?
|
| Pneumonia | 1 | 2021 | 2133 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1257 | 0.090 |
Why?
|
| Animals | 20 | 2019 | 168757 | 0.080 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2009 | 56 | 0.080 |
Why?
|
| Killer Cells, Natural | 2 | 2016 | 2133 | 0.080 |
Why?
|
| Personal Autonomy | 1 | 2011 | 298 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2014 | 3002 | 0.080 |
Why?
|
| Male | 17 | 2023 | 350118 | 0.080 |
Why?
|
| Anesthesia, Epidural | 1 | 2011 | 228 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 684 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2014 | 7880 | 0.080 |
Why?
|
| Receptors, Cell Surface | 3 | 2012 | 2866 | 0.080 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2011 | 271 | 0.080 |
Why?
|
| Cell Differentiation | 7 | 2009 | 11483 | 0.080 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 1077 | 0.080 |
Why?
|
| Receptors, IgG | 2 | 2022 | 582 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10180 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 186 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2004 | 3617 | 0.080 |
Why?
|
| Religion | 1 | 2011 | 356 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 4328 | 0.080 |
Why?
|
| Sex Factors | 1 | 2021 | 10397 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2942 | 0.080 |
Why?
|
| Ultrasonography | 4 | 2017 | 5985 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 662 | 0.070 |
Why?
|
| Iron | 1 | 2015 | 1774 | 0.070 |
Why?
|
| Stomach | 2 | 2004 | 697 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5952 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
| Apnea | 1 | 2008 | 195 | 0.070 |
Why?
|
| Prenatal Diagnosis | 3 | 2020 | 1236 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2018 | 4217 | 0.070 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 602 | 0.070 |
Why?
|
| Smad8 Protein | 1 | 2005 | 17 | 0.070 |
Why?
|
| Pandemics | 3 | 2021 | 8388 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2005 | 27 | 0.070 |
Why?
|
| Ethics, Medical | 1 | 2011 | 792 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 1059 | 0.070 |
Why?
|
| Neurons | 1 | 2005 | 9338 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 134 | 0.070 |
Why?
|
| Maternal Welfare | 1 | 2006 | 115 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2016 | 2921 | 0.070 |
Why?
|
| Smad1 Protein | 1 | 2005 | 81 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 813 | 0.070 |
Why?
|
| Ectoderm | 1 | 2005 | 137 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2005 | 8436 | 0.070 |
Why?
|
| Stroke | 1 | 2008 | 9981 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1142 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2016 | 2508 | 0.060 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2005 | 68 | 0.060 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 20 | 0.060 |
Why?
|
| Smoking | 3 | 2020 | 8987 | 0.060 |
Why?
|
| Particulate Matter | 1 | 2016 | 2530 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 2009 | 934 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 643 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18029 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2004 | 187 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12245 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2011 | 4838 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2022 | 1534 | 0.060 |
Why?
|
| Neoplasms | 3 | 2018 | 21683 | 0.060 |
Why?
|
| Fever | 1 | 2011 | 1616 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 350 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 19905 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2009 | 1381 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2008 | 1097 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 9648 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2006 | 552 | 0.060 |
Why?
|
| Triplets | 1 | 2002 | 43 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7181 | 0.050 |
Why?
|
| Digestive System Abnormalities | 1 | 2002 | 52 | 0.050 |
Why?
|
| Malaria | 2 | 2015 | 1239 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 1366 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 2004 | 449 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2016 | 2817 | 0.050 |
Why?
|
| Epithelial Cells | 3 | 2006 | 3690 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2004 | 224 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 193 | 0.050 |
Why?
|
| Apoptosis | 2 | 2017 | 9727 | 0.050 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2002 | 61 | 0.050 |
Why?
|
| North Dakota | 1 | 2021 | 14 | 0.050 |
Why?
|
| South Dakota | 1 | 2021 | 30 | 0.050 |
Why?
|
| Urogenital System | 1 | 2002 | 86 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 2109 | 0.050 |
Why?
|
| Tail | 1 | 2002 | 97 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2263 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2009 | 1376 | 0.050 |
Why?
|
| Lyme Disease | 1 | 2007 | 621 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 1353 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2015 | 3336 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2002 | 136 | 0.050 |
Why?
|
| Patient Selection | 1 | 2013 | 4215 | 0.050 |
Why?
|
| Middle Aged | 8 | 2021 | 213383 | 0.050 |
Why?
|
| United States | 4 | 2021 | 69872 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 41006 | 0.050 |
Why?
|
| Lactobacillus | 1 | 2021 | 189 | 0.050 |
Why?
|
| Diagnosis | 1 | 2021 | 154 | 0.050 |
Why?
|
| Ethanol | 1 | 2007 | 1342 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2009 | 2504 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2023 | 53288 | 0.050 |
Why?
|
| Mutation | 5 | 2011 | 29786 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 23338 | 0.040 |
Why?
|
| Public Health | 1 | 2013 | 2603 | 0.040 |
Why?
|
| Ferritins | 1 | 2022 | 590 | 0.040 |
Why?
|
| Forms and Records Control | 1 | 2020 | 160 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2088 | 0.040 |
Why?
|
| Plasma Exchange | 1 | 2020 | 152 | 0.040 |
Why?
|
| Fetal Development | 2 | 2020 | 767 | 0.040 |
Why?
|
| Epithelium | 1 | 2004 | 1679 | 0.040 |
Why?
|
| Viremia | 1 | 2022 | 736 | 0.040 |
Why?
|
| Prenatal Care | 2 | 2017 | 1092 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2020 | 161 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 547 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2002 | 261 | 0.040 |
Why?
|
| Thrombocytopenia | 2 | 2004 | 1179 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 1903 | 0.040 |
Why?
|
| Biodiversity | 1 | 2021 | 341 | 0.040 |
Why?
|
| Nervous System | 1 | 2002 | 554 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 1613 | 0.040 |
Why?
|
| Time Factors | 3 | 2017 | 40075 | 0.040 |
Why?
|
| Viscera | 1 | 1998 | 139 | 0.040 |
Why?
|
| Ligands | 1 | 2005 | 3282 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 379 | 0.040 |
Why?
|
| Pelvis | 1 | 2022 | 730 | 0.040 |
Why?
|
| Liver | 3 | 2017 | 7474 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 954 | 0.040 |
Why?
|
| Wisconsin | 1 | 2017 | 124 | 0.040 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2006 | 808 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 1005 | 0.040 |
Why?
|
| Peptides | 1 | 2009 | 4409 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2022 | 2044 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2022 | 1041 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1526 | 0.040 |
Why?
|
| Placental Function Tests | 1 | 2016 | 3 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2020 | 456 | 0.040 |
Why?
|
| Models, Biological | 3 | 2016 | 9583 | 0.040 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2017 | 89 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1200 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2022 | 1470 | 0.040 |
Why?
|
| Extremities | 1 | 2002 | 865 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2012 | 4256 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 63114 | 0.030 |
Why?
|
| Myocardium | 1 | 2009 | 4776 | 0.030 |
Why?
|
| South Africa | 1 | 2021 | 1731 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 879 | 0.030 |
Why?
|
| Thrombin | 1 | 2018 | 598 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1537 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2016 | 205 | 0.030 |
Why?
|
| Colon | 1 | 2004 | 1772 | 0.030 |
Why?
|
| Syndrome | 1 | 2002 | 3251 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2005 | 3420 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4851 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
| Seizures | 1 | 2008 | 2859 | 0.030 |
Why?
|
| Child | 2 | 2022 | 77709 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4479 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 2988 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 2017 | 477 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2012 | 2649 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 6364 | 0.030 |
Why?
|
| Plasma | 1 | 2018 | 575 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13989 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6171 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 2749 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2715 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 458 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14722 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2003 | 2240 | 0.030 |
Why?
|
| Documentation | 1 | 2020 | 871 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 675 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 2085 | 0.030 |
Why?
|
| Karyotyping | 1 | 2016 | 1243 | 0.030 |
Why?
|
| Parturition | 1 | 2017 | 441 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 3036 | 0.030 |
Why?
|
| Prognosis | 2 | 2012 | 29063 | 0.030 |
Why?
|
| Cell Movement | 1 | 2005 | 5217 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 18111 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 850 | 0.030 |
Why?
|
| Protein Binding | 1 | 2005 | 9386 | 0.030 |
Why?
|
| Death | 1 | 2017 | 678 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15540 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2017 | 12026 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
| Receptors, KIR | 1 | 2012 | 113 | 0.030 |
Why?
|
| Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2005 | 5021 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5179 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 1126 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.020 |
Why?
|
| Logistic Models | 2 | 2020 | 13408 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 847 | 0.020 |
Why?
|
| Mice | 7 | 2016 | 81183 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 2126 | 0.020 |
Why?
|
| Microdissection | 1 | 2011 | 152 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 294 | 0.020 |
Why?
|
| Term Birth | 1 | 2011 | 135 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2002 | 3461 | 0.020 |
Why?
|
| Endometrial Hyperplasia | 1 | 2011 | 97 | 0.020 |
Why?
|
| Genotype | 2 | 2017 | 12951 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 560 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
| Cell Division | 2 | 2009 | 4568 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2020 | 2616 | 0.020 |
Why?
|
| Phenotype | 2 | 2017 | 16365 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10481 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7799 | 0.020 |
Why?
|
| Obesity | 2 | 2023 | 12745 | 0.020 |
Why?
|
| Mosaicism | 1 | 2011 | 441 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 500 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1866 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 8428 | 0.020 |
Why?
|
| Myometrium | 1 | 2008 | 181 | 0.020 |
Why?
|
| Brain | 2 | 2017 | 26385 | 0.020 |
Why?
|
| Testosterone | 1 | 2017 | 2420 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1990 | 0.020 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 21827 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9438 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5256 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1706 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1856 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1341 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 732 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1878 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2009 | 3479 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20129 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 2004 | 85 | 0.020 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2004 | 130 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2009 | 2716 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2007 | 597 | 0.010 |
Why?
|
| Perforin | 1 | 2004 | 168 | 0.010 |
Why?
|
| Pylorus | 1 | 2004 | 86 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2004 | 190 | 0.010 |
Why?
|
| Veratrum Alkaloids | 1 | 2003 | 25 | 0.010 |
Why?
|
| Leukopenia | 1 | 2004 | 212 | 0.010 |
Why?
|
| Sirolimus | 1 | 2011 | 1564 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2004 | 200 | 0.010 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2007 | 378 | 0.010 |
Why?
|
| SOX9 Transcription Factor | 1 | 2004 | 146 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 240 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 689 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11031 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 1741 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2004 | 188 | 0.010 |
Why?
|
| Proteins | 1 | 1998 | 6103 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2003 | 162 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2012 | 2258 | 0.010 |
Why?
|
| Hormones | 1 | 2007 | 889 | 0.010 |
Why?
|
| Echoencephalography | 1 | 2003 | 135 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2004 | 458 | 0.010 |
Why?
|
| Steroids | 1 | 2008 | 930 | 0.010 |
Why?
|
| Purpura | 1 | 2003 | 122 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 440 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2017 | 6256 | 0.010 |
Why?
|
| Biological Transport | 1 | 2007 | 2118 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2006 | 644 | 0.010 |
Why?
|
| Gastrula | 1 | 2002 | 84 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 433 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2002 | 112 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 1970 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1294 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3557 | 0.010 |
Why?
|
| Smad Proteins | 1 | 2002 | 162 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 2004 | 337 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2004 | 599 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2948 | 0.010 |
Why?
|
| Genes, ras | 1 | 2003 | 690 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1637 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1850 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 5751 | 0.010 |
Why?
|
| Blastocyst | 1 | 2002 | 424 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 732 | 0.010 |
Why?
|
| Inflammation | 2 | 2012 | 10638 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1676 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 3689 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2006 | 4199 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6314 | 0.010 |
Why?
|
| Heart | 1 | 2009 | 4467 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 2382 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2004 | 2564 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 8301 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15997 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13815 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3768 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 163280 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2541 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 3444 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 7186 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 24260 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 16689 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57776 | 0.000 |
Why?
|